Jump Financial’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,387
Closed -$81.9K – 2711
2026
Q2
$81.9K Buy
23,387
+2,844
+14% +$10.8K ﹤0.01% 1916
2026
Q1
$79.3K Sell
20,543
-15,777
-43% -$62.1K ﹤0.01% 1768
2025
Q4
$143K Buy
+36,320
New +$161K ﹤0.01% 1795
2024
Q4
– Sell
-10,999
Closed -$64.3K – 2054
2024
Q3
$64.3K Buy
+10,999
New +$80K ﹤0.01% 1550
2024
Q2
– Sell
-16,168
Closed -$151K – 2313
2024
Q1
$151K Buy
+16,168
New +$136K ﹤0.01% 1747
2023
Q2
– Sell
-16,300
Closed -$126K – 2201
2023
Q1
$126K Buy
16,300
+5,817
+55% +$46.3K 0.01% 1405
2022
Q4
$63.9K Sell
10,483
-15,517
-60% -$88.2K ﹤0.01% 1477
2022
Q3
$154K Sell
26,000
-9,778
-27% -$62.6K 0.01% 1393
2022
Q2
$211K Sell
35,778
-1,169
-3% -$7.9K 0.01% 1273
2022
Q1
$281K Buy
36,947
+18,347
+99% +$81.8K 0.01% 1103
2021
Q4
$50K Buy
+18,600
New +$63.5K ﹤0.01% 1308

Other funds holding VYGR

Jump Financial's VYGR Position: Q3 2026 in Review

Jump Financial sold out of Voyager Therapeutics (VYGR) in Q3 2026, closing a stake of 23,387 shares — an estimated $81.9K sold.

Jump Financial first reported a position in VYGR in Q4 2021 and held it in 11 quarters. The position peaked at $281K in Q1 2022. 121 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.

  • Jump Financial reported no remaining Voyager Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jump Financial sold 23,387 Voyager Therapeutics shares in Q3 2026, an estimated $81.9K.
  • Jump Financial first reported a position in Voyager Therapeutics in Q4 2021 and held it in 11 quarters.
  • Jump Financial's Voyager Therapeutics position peaked at $281K in Q1 2022.
  • 121 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.